InvestorsObserver
×
News Home

Do Analysts Expect Castle Biosciences Inc (CSTL) Stock to Rise After It Is Lower By -17.77% in a Month?

Monday, May 10, 2021 12:19 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Castle Biosciences Inc (CSTL) Stock to Rise After It Is Lower By -17.77% in a Month?

InvestorsObserver is giving Castle Biosciences Inc (CSTL) an Analyst Rating Rank of 76, meaning CSTL is ranked higher by analysts than 76% of stocks. The average price target for CSTL is $86.5 and analyst’s rate the stock as a Hold

Overall Score - 5
Wall Street analysts are rating CSTL a Hold today. Find out what this means to you and get the rest of the rankings on CSTL!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.

InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Castle Biosciences Inc Stock Today?

Castle Biosciences Inc (CSTL) stock is lower by -7.95% while the S&P 500 is up 0.02% as of 12:16 PM on Monday, May 10. CSTL is lower by -$4.79 from the previous closing price of $60.32 on volume of 148,599 shares. Over the past year the S&P 500 has gained 44.46% while CSTL is up 70.86%. CSTL lost -$0.54 per share the over the last 12 months.

Click Here to get the full report on Castle Biosciences Inc (CSTL) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App